Anika Therapeutics ANIK Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's total current liabilities?
- Anika Therapeutics (ANIK) reported total current liabilities of $20.97M in Q1 2026.
- How has Anika Therapeutics's total current liabilities changed year-over-year?
- Anika Therapeutics's total current liabilities increased by 17.1% year-over-year, from $17.9M to $20.97M.
- What is the long-term trend for Anika Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Anika Therapeutics's total current liabilities has grown at a -9.9% compound annual growth rate (CAGR), from $36.87M to $21.91M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.